Standard
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*. / Cozzi-Lepri, A; Paredes, R; Phillips, A N; Clotet, B; Kjær, Jesper; Von Wyl, V; Kronborg, Gitte; Castagna, A; Bogner, J R; Lundgren, Jens; EuroSIDA in EuroCoord.
In:
HIV Medicine, Vol. 13, No. 1, 01.2012, p. 62-72.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Cozzi-Lepri, A, Paredes, R, Phillips, AN, Clotet, B, Kjær, J, Von Wyl, V
, Kronborg, G, Castagna, A, Bogner, JR
, Lundgren, J & EuroSIDA in EuroCoord 2012, '
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*',
HIV Medicine, vol. 13, no. 1, pp. 62-72.
https://doi.org/10.1111/j.1468-1293.2011.00943.xAPA
Cozzi-Lepri, A., Paredes, R., Phillips, A. N., Clotet, B., Kjær, J., Von Wyl, V.
, Kronborg, G., Castagna, A., Bogner, J. R.
, Lundgren, J., & EuroSIDA in EuroCoord (2012).
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*.
HIV Medicine,
13(1), 62-72.
https://doi.org/10.1111/j.1468-1293.2011.00943.xVancouver
Cozzi-Lepri A, Paredes R, Phillips AN, Clotet B, Kjær J, Von Wyl V et al.
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*.
HIV Medicine. 2012 Jan;13(1):62-72.
https://doi.org/10.1111/j.1468-1293.2011.00943.xAuthor
Cozzi-Lepri, A ; Paredes, R ; Phillips, A N ; Clotet, B ; Kjær, Jesper ; Von Wyl, V ; Kronborg, Gitte ; Castagna, A ; Bogner, J R ; Lundgren, Jens ; EuroSIDA in EuroCoord. / The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*. In: HIV Medicine. 2012 ; Vol. 13, No. 1. pp. 62-72.
Bibtex
@article{9c89b442b9ae4cb18a3d5f9d8a813549,
title = "The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*",
abstract = "Virological failure of first-generation nonnucleoside reverse transcriptase inhibitors (NNRTIs) can compromise the efficacy of etravirine as a result of the accumulation of NNRTI resistance mutations. How quickly NNRTI resistance accumulates in patients with a delayed switch from nevirapine or efavirenz despite virological failure, when these drugs are used as a component of combination antiretroviral therapy (cART), remains unclear.",
author = "A Cozzi-Lepri and R Paredes and Phillips, {A N} and B Clotet and Jesper Kj{\ae}r and {Von Wyl}, V and Gitte Kronborg and A Castagna and Bogner, {J R} and Jens Lundgren and Gitte Kronborg",
note = "{\textcopyright} 2011 British HIV Association.",
year = "2012",
month = jan,
doi = "10.1111/j.1468-1293.2011.00943.x",
language = "English",
volume = "13",
pages = "62--72",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell",
number = "1",
}
RIS
TY - JOUR
T1 - The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*
AU - Cozzi-Lepri, A
AU - Paredes, R
AU - Phillips, A N
AU - Clotet, B
AU - Kjær, Jesper
AU - Von Wyl, V
AU - Kronborg, Gitte
AU - Castagna, A
AU - Bogner, J R
AU - Lundgren, Jens
AU - EuroSIDA in EuroCoord
N1 - © 2011 British HIV Association.
PY - 2012/1
Y1 - 2012/1
N2 - Virological failure of first-generation nonnucleoside reverse transcriptase inhibitors (NNRTIs) can compromise the efficacy of etravirine as a result of the accumulation of NNRTI resistance mutations. How quickly NNRTI resistance accumulates in patients with a delayed switch from nevirapine or efavirenz despite virological failure, when these drugs are used as a component of combination antiretroviral therapy (cART), remains unclear.
AB - Virological failure of first-generation nonnucleoside reverse transcriptase inhibitors (NNRTIs) can compromise the efficacy of etravirine as a result of the accumulation of NNRTI resistance mutations. How quickly NNRTI resistance accumulates in patients with a delayed switch from nevirapine or efavirenz despite virological failure, when these drugs are used as a component of combination antiretroviral therapy (cART), remains unclear.
U2 - 10.1111/j.1468-1293.2011.00943.x
DO - 10.1111/j.1468-1293.2011.00943.x
M3 - Journal article
C2 - 21848790
VL - 13
SP - 62
EP - 72
JO - HIV Medicine
JF - HIV Medicine
SN - 1464-2662
IS - 1
ER -
